Authors
Markus Huber, Ekin Sahin, Lance D Presser, Kazunobu Kojima, Joanna Salvi Le Garrec
Published in
Bulletin of the World Health Organization. Volume 104. Issue 11. Pages 722-731. Nov 01, 2026. Epub Sep 09, 2026.
Abstract
To examine international agreements, standards, policy documents and regulations governing the cross-border transportation of infectious substances and to assess the extent to which fragmented regulatory frameworks affect timely and safe shipment.
A qualitative document analysis of 30 binding and non-binding legal and policy instruments was conducted and details were entered into a common extraction grid. In addition, the published reports and 64 international participants of World Health Organization (WHO) subregional workshops on the transport of infectious substances legislation, in Istanbul, Türkiye (2022) and Almaty, Kazakhstan (2023), provided an operational perspective. No other interviews or consultations were undertaken.
The analysis revealed substantial fragmentation and inconsistency in regulatory frameworks governing the cross-border transportation of infectious substances. Although many countries had ratified or referenced international agreements in national legislation, harmonized and cross-departmental implementation of legislation was lacking. Limitations included: (i) the incomplete adoption of international shipping standards; (ii) bureaucratic delays in approval and licensing processes; (iii) limited technical capacity; and (iv) a lack of standardized procedures and enforcement mechanisms.
The international regulatory environment for infectious substance transport is complex and targeted interventions are needed, such as harmonizing regulatory frameworks, improving interagency coordination, investing in capacity-building, developing standard operating procedures and aligning policy documents with international best practice. These interventions will help countries meet their obligations under the International Health Regulations (2005), enhance the safe and secure transport of infectious substances and improve global public health preparedness, as required by the recent WHO Pandemic Agreement.
PMID:
42974156
Bibliographic data and abstract were imported from PubMed on 03 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 16
- Comments 0